Does Rallies show Form 4 insider transactions for RMTI?

Yes. Rallies tracks RMTI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RMTI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RMTI. It does not provide personalized investment advice.

RMTI (Rockwell Medical, Inc. (DE) Common Stock) Stock Analysis - Insider Trades

Rockwell Medical, Inc. (DE) Common Stock (RMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, RMTI trades at $0.82 with a market cap of $30.84M and a P/E ratio of -5.45. RMTI moved +2.23% today. Year to date, RMTI is -17.00%; over the trailing twelve months it is -23.36%. Its 52-week range spans $0.74 to $5.15. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RMTI stock inside the company?

Recent RMTI insider activity includes Hunter Heather sold 2.87K, Neri Jesse sold 886, COOPER JOHN G sold 5.08K, Hunter Heather sold 2.87K, and Chole Timothy sold 2.87K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RMTI Key Metrics

Key financial metrics for RMTI
Metric	Value
Price	$0.82
Market Cap	$30.84M
P/E Ratio	-5.45
EPS	$-0.15
Dividend Yield	0.00%
52-Week High	$5.15
52-Week Low	$0.74
Volume	0
Avg Volume	0
Revenue (TTM)	$67.68M
Net Income	$-5.40M
Gross Margin	17.07%

Recent RMTI Insider Trades

Hunter Heather sold 2.87K (~$2.40K) on Jan 2, 2026.
Neri Jesse sold 886 (~$740.253) on Jan 2, 2026.
COOPER JOHN G sold 5.08K (~$4.42K) on Nov 18, 2025.
Hunter Heather sold 2.87K (~$3.41K) on Oct 1, 2025.
Chole Timothy sold 2.87K (~$3.41K) on Oct 1, 2025.

Latest RMTI News

Rockwell Medical Targets Q4 Profitability in Updated 2026 Guidance with Q1 Results — May 7, 2026
Rockwell Medical Q4 Revenue Up 15% to $18.3M, EBITDA $1M — Mar 26, 2026
Rockwell Medical Expands to 300 Customers, Forecasts $1–2M EBITDA and $100M Sales — Mar 26, 2026
Rockwell Medical Gains 13.3% Over 12 Weeks with 5.5% Month Surge — Feb 16, 2026

RMTI Analyst Consensus

2 analysts cover RMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.

Common questions about RMTI

Who is trading RMTI stock inside the company?: Recent RMTI insider activity includes Hunter Heather sold 2.87K, Neri Jesse sold 886, COOPER JOHN G sold 5.08K, Hunter Heather sold 2.87K, and Chole Timothy sold 2.87K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RMTI?: Yes. Rallies tracks RMTI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RMTI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RMTI. It does not provide personalized investment advice.